TY - JOUR
T1 - p27Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma
AU - Armengol, Carolina
AU - Boix, Loreto
AU - Bachs, Oriol
AU - Solé, Manel
AU - Fuster, Josep
AU - Sala, Margarita
AU - Llovet, Josep M.
AU - Rodés, Juan
AU - Bruix, Jordi
N1 - Funding Information:
This study was supported by grants from the Comisión Interdepartamental de Ciencia y Tecnologı́a (SAF98-004 and SAF99-028). C.A. is supported by research grants from the Ministerio de Ciencia y Tecnologı́a and from the Fundació Rius i Virgili. J.M.L. is a recipient of a contract from Programa ‘Ramon y Cajal’ (Ministerio de Ciencia y Tecnologı́a). M.S. has a grant from the Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo). The authors thank Margarita Mainar and Elena Gonzalvo for their technical assistance in immunohistochemistry.
PY - 2003/5/1
Y1 - 2003/5/1
N2 - Background/Aims: Alterations in p27Kip1 (p27) and cyclin E (cycE) expression are found in tumors and are related to poor prognosis. This study assesses the role of these cell cycle regulators in the development of recurrence after surgical resection in 46 cirrhotic patients (age: 61.3 ± 7 years, 30 males, 44 Child-Pugh's A, 30 HCV-positive) with small hepatocellular carcinoma (HCC, size: 3.1 ± 1.5 cm, 40 solitary at pathological examination). Methods: p27 and cycE expression in tumoral and non-tumoral liver were analyzed by Western blot (WB). p27 was also assessed by immunohistochemistry (IHC). Results: Tumor p27 underexpression (50% decreased vs. non-tumoral liver) occurred in 12 cases. Throughout follow-up, 26 patients developed recurrence, which was significantly higher in patients with p27 underexpression than in those without (3-year recurrence: 80 vs. 44%, respectively, P = 0.026). IHC showed concordant inverse findings: 13 tumors showed high p27 staining that was related to lower recurrence rate (P = 0.019). Multivariate analysis identified p27 measured by WB as an improved predictor of recurrence (OR: 3.09, 95% CI: 1.26-7.08, P = 0.016). By contrast, cycE, increased in 66 % of the tumors, had no impact on recurrence but was associated to poor differentiation (P = 0.015) and microvascular invasion (P = 0.016). Conclusions: p27 underexpression is frequent in relatively early stages of HCC and constitutes an independent predictor of recurrence after surgical resection.
AB - Background/Aims: Alterations in p27Kip1 (p27) and cyclin E (cycE) expression are found in tumors and are related to poor prognosis. This study assesses the role of these cell cycle regulators in the development of recurrence after surgical resection in 46 cirrhotic patients (age: 61.3 ± 7 years, 30 males, 44 Child-Pugh's A, 30 HCV-positive) with small hepatocellular carcinoma (HCC, size: 3.1 ± 1.5 cm, 40 solitary at pathological examination). Methods: p27 and cycE expression in tumoral and non-tumoral liver were analyzed by Western blot (WB). p27 was also assessed by immunohistochemistry (IHC). Results: Tumor p27 underexpression (50% decreased vs. non-tumoral liver) occurred in 12 cases. Throughout follow-up, 26 patients developed recurrence, which was significantly higher in patients with p27 underexpression than in those without (3-year recurrence: 80 vs. 44%, respectively, P = 0.026). IHC showed concordant inverse findings: 13 tumors showed high p27 staining that was related to lower recurrence rate (P = 0.019). Multivariate analysis identified p27 measured by WB as an improved predictor of recurrence (OR: 3.09, 95% CI: 1.26-7.08, P = 0.016). By contrast, cycE, increased in 66 % of the tumors, had no impact on recurrence but was associated to poor differentiation (P = 0.015) and microvascular invasion (P = 0.016). Conclusions: p27 underexpression is frequent in relatively early stages of HCC and constitutes an independent predictor of recurrence after surgical resection.
KW - Cyclin E
KW - Hepatocellular carcinoma
KW - Immunohistochemistry
KW - Recurrence
KW - Surgical resection
KW - Western blot
KW - p27
UR - http://www.scopus.com/inward/record.url?scp=0037879095&partnerID=8YFLogxK
U2 - 10.1016/S0168-8278(03)00025-4
DO - 10.1016/S0168-8278(03)00025-4
M3 - Article
C2 - 12713869
AN - SCOPUS:0037879095
SN - 0168-8278
VL - 38
SP - 591
EP - 597
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 5
ER -